» Articles » PMID: 8138807

Content of Mutant Mitochondrial DNA and Organ Dysfunction in a Patient with a MELAS Subgroup of Mitochondrial Encephalomyopathies

Overview
Journal J Neurol Sci
Publisher Elsevier
Specialty Neurology
Date 1993 Dec 15
PMID 8138807
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

A point mutation of mitochondrial tRNALeu(UUR) gene is responsible for a MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes) subgroup of mitochondrial encephalomyopathies. In most cases, the mutant mitochondrial DNA (mtDNA) coexists with normal mtDNA in a heteroplasmic manner. In order to quantify the content of mutant mtDNA, we developed a quantitative method of PCR. Using this method, the distribution of the mutant mtDNA was examined in 32 different tissues among 18 autopsied organs from a patient with MELAS, who had shown hypophyseal dysfunction. The percentage of the mutant mtDNA at nucleotide number 3243 in each tissue was ranged between 22% and 95%. The content of the mutant mtDNA was at the highest (95%) in the hypophysis and higher in the cerebral cortex than in the white matter. This study shows a possible correlation of tissue dysfunction with accumulation of the mutant mtDNA within the brain.

Citing Articles

Red Flags in Primary Mitochondrial Diseases: What Should We Recognize?.

Conti F, Di Martino S, Drago F, Bucolo C, Micale V, Montano V Int J Mol Sci. 2023; 24(23).

PMID: 38069070 PMC: 10706469. DOI: 10.3390/ijms242316746.


Endocrine features of primary mitochondrial diseases.

Romo L, Gold N, Walker M Curr Opin Endocrinol Diabetes Obes. 2023; 31(1):34-42.

PMID: 38047549 PMC: 10734788. DOI: 10.1097/MED.0000000000000848.


Comprehensive summary of mitochondrial DNA alterations in the postmortem human brain: A systematic review.

Valiente-Palleja A, Tortajada J, Bulduk B, Vilella E, Garrabou G, Muntane G EBioMedicine. 2022; 76:103815.

PMID: 35085849 PMC: 8790490. DOI: 10.1016/j.ebiom.2022.103815.


Heteroplasmy and Copy Number in the Common m.3243A>G Mutation-A Post-Mortem Genotype-Phenotype Analysis.

Scholle L, Zierz S, Mawrin C, Wickenhauser C, Lehmann Urban D Genes (Basel). 2020; 11(2).

PMID: 32085658 PMC: 7073558. DOI: 10.3390/genes11020212.


Height as a Clinical Biomarker of Disease Burden in Adult Mitochondrial Disease.

Boal R, Ng Y, Pickett S, Schaefer A, Feeney C, Bright A J Clin Endocrinol Metab. 2018; 104(6):2057-2066.

PMID: 30423112 PMC: 6469958. DOI: 10.1210/jc.2018-00957.